Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
Health Minister Jane Philpott has authorized naloxone nasal spray for non-prescription use. (Hand-out/Adapt Pharma)
Health Minister Jane Philpott has authorized naloxone nasal spray for non-prescription use. (Hand-out/Adapt Pharma)

Health Canada approves non-prescription naloxone nasal spray Add to ...

Health Minister Jane Philpott has authorized naloxone nasal spray for non-prescription use to help prevent deaths from opioid overdoses.

Naloxone, sold under the brand name Narcan, can reverse the effects of an opioid overdose if used promptly.

Monday’s move follows an interim order by Philpott in July that allowed naloxone nasal spray to be imported from the U.S. Only the injectable version of the drug had been approved in Canada.

The nasal spray is considered easier to administer than the injectable version, especially for those who aren’t trained health-care professionals.

Health Canada says the nasal spray’s manufacturer can now take the necessary steps to officially bring the product to market in Canada.

Until then, the U.S.-approved product will continue to be available in Canada to avoid interruption in supply.

Report Typo/Error

Also on The Globe and Mail

B.C. fentanyl overdose crisis prompts supervised injection sites to introduce testing (The Globe and Mail)

Next story

loading

In the know

The Globe Recommends

loading

Most popular videos »

Highlights

More from The Globe and Mail

Most popular